U.S. Markets closed

Puissance Capital Management LP Buys SCYNEXIS Inc

Investment company Puissance Capital Management LP (Current Portfolio) buys SCYNEXIS Inc during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Puissance Capital Management LP. As of 2019Q2, Puissance Capital Management LP owns 7 stocks with a total value of $102 million. These are the details of the buys and sells.

  • New Purchases: SCYX,

For the details of Puissance Capital Management LP's stock buys and sells,
go to https://www.gurufocus.com/guru/puissance+capital+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Puissance Capital Management LP

  1. ViewRay Inc (VRAY) - 6,842,975 shares, 59.00% of the total portfolio.
  2. Ekso Bionics Holdings Inc (EKSO) - 20,534,898 shares, 25.52% of the total portfolio.
  3. Kadmon Holdings Inc (KDMN) - 3,020,596 shares, 6.02% of the total portfolio.
  4. Bellerophon Therapeutics Inc (BLPH) - 8,298,755 shares, 4.87% of the total portfolio.
  5. TRACON Pharmaceuticals Inc (TCON) - 4,601,768 shares, 3.06% of the total portfolio.

New Purchase: SCYNEXIS Inc (SCYX)

Puissance Capital Management LP initiated holding in SCYNEXIS Inc. The purchase prices were between $1.09 and $1.85, with an estimated average price of $1.44. The stock is now traded at around $1.05. The impact to a portfolio due to this purchase was 0.49%. The holding were 378,811 shares as of .



Here is the complete portfolio of Puissance Capital Management LP. Also check out:

1. Puissance Capital Management LP's Undervalued Stocks

2. Puissance Capital Management LP's Top Growth Companies, and

3. Puissance Capital Management LP's High Yield stocks

4. Stocks that Puissance Capital Management LP keeps buyingThis article first appeared on GuruFocus.